Cargando…
Reappraisal on pharmacological and mechanical treatments of heart failure
Heart failure (HF) is a highly frequent disorder with considerable morbidity, hospitalization, and mortality; thus, it invariably places pressure on clinical and public health systems in the modern world. There have been notable advances in the definition, diagnosis, and treatment of HF, and newly d...
Autores principales: | Liang, Bo, Zhao, Yu-Xiu, Zhang, Xiao-Xiao, Liao, Hui-Ling, Gu, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202267/ https://www.ncbi.nlm.nih.gov/pubmed/32375806 http://dx.doi.org/10.1186/s12933-020-01024-5 |
Ejemplares similares
-
Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction
por: Liang, Bo, et al.
Publicado: (2022) -
Pulmonary Embolism and Heart Failure: A Reappraisal
por: Arrigo, Mattia, et al.
Publicado: (2021) -
Exploring Molecular Mechanism of Huangqi in Treating Heart Failure Using Network Pharmacology
por: Tao, Yan-gu, et al.
Publicado: (2020) -
Recent advances in pharmacological treatment of heart failure
por: Iacoviello, Massimo, et al.
Publicado: (2021) -
Empagliflozin improves cardiac function in heart failure with reduced ejection fraction independent of loading conditions
por: Liang, Bo, et al.
Publicado: (2020)